Activity-Dependent Inhibitory Synaptogenesis in Cerebellar Cultures.

Inhibitory synapses on Purkinje cell somata in organotypic cerebellar cultures derived from newborn mice were increased after chronic exposure post explantation to agents that enhance neuronal activity. Inhibitory synaptogenesis was reduced in similar cultures after continuous blockade of spontaneous neuronal discharges. By contrast, excitatory synapses developed fully in the absence of neuronal activity. The reduction of inhibitory synaptogenesis was prevented by the simultaneous application of activity blocking agents and neurotrophins BDNF or NT-4, which are TrkB receptor ligands, but not with NT-3, a TrkC receptor ligand. The effect of endogenous neurotrophins was evaluated by continuously exposing cerebellar cultures to antibodies to BDNF and NT-4, which caused a significant reduction in the development of inhibitory Purkinje cell axosomatic synapses. These combined results indicated a role for TrkB receptors in activity-dependent inhibitory synaptogenesis. This concept was supported by the promotion of inhibitory synaptogenesis by specific antibody activation of TrkB receptors.

INTRODUCTION

Neuronal activity is critical for development of some parts of the nervous system, including visual [1-5], auditory [6], olfactory [7] and somatosensory [8] systems. Data derived from both animal studies [9-13] and studies with nervous system cultures [14-20] indicated that neuronal activity is necessary for the development of the full complement of inhibitory synapses. By contrast, an induced increase in neuronal activity both accelerated and augmented inhibitory synapse formation [21-23].

Neurotrophins appear to have essential roles in activity-dependent plastic changes [24-26]. The neurotrophin family members include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4). The high affinity receptor tyrosine kinases with which they bind are TrkA for NGF, TrkB for BDNF and NT-4 and TrkC for NT-3 [27-29]. In a study in which neuronal activity was blocked in dissociated visual cortex cultures containing GABAergic interneurons and target pyramidal cells, Rutherford et al. [30] found that the percentage of GABA-immunopositive neurons was reduced and that pyramidal cell discharge rates were increased. The effects of activity blockade were prevented by simultaneous exposure of the cultures to BDNF, but not to NGF or NT-3 (NT-4 was not tested). The authors concluded that activity regulates cortical inhibition by regulation of BDNF.

In this brief review I will describe studies from my laboratory of the effects of both enhancement and blockade of neuronal activity in organotypic cerebellar cultures derived from newborn mice, and of the consequences of simultaneous application of activity blocking agents and neurotrophins. More extensive reviews have been published [31, 32].

THE MODEL

The organotypic cerebellar culture model system was chosen because the contained cortical neuronal types and their functions are known, allowing quantitative studies of synaptogenesis and correlation with electrophysiological data. Structural and functional roles of cortical neurons of the rodent cerebellum in vivo had been well defined [33, 34]. In a series of studies we determined that the same structural and functional relationships developed in organotypic cerebellar cultures [35-39]. As such cultures were derived from newborn mice at a time when there was very little development of cortical synapses, most of the cortical synaptogenesis occurred in vitro.

The cultures were prepared by trimming the lateral tips of the isolated cerebella and then dividing each cerebellum into seven parasagittaly oriented slices. Each explant was placed onto a collagen coated coverslip with a drop of nutrient medium and incorporated into a Maximow chamber [40, 41]. The standard nutrient medium, which was replaced twice weekly, consisted of two parts 3 IU/ml low-zinc insulin, one part 20% dextrose, eight parts Eagle’s minimum essential medium with Hanks’ base and added L-glutamine, seven parts Simms’ X-7 balanced salt solution (BSS) with incorporated HEPES buffer (pH 7.4) to make its concentration 10–2 M in the fully constituted medium, and twelve parts fetal calfserum.

Definable cortical and subcortical regions with myelinated axons in between were evident by two weeks in vitro. All of the major cortical neuronal types were represented, including Purkinje, granule, basket, stellate and Golgi cells. Their afferent and efferent projections are diagrammed in Fig. 1. Purkinje cells, which are inhibitory, are the only neurons which project their axons beyond the cerebellar cortex. In addition, they project axon collaterals to all other cortical neurons, including other Purkinje cells. Granule cells are the only excitatory cortical neurons, and they project axons as bundles of parallel fibers to the dendrites of all other cortical neurons and form numerous synapses with Purkinje cell dendritic spines. The remaining cortical neurons are inhibitory interneurons. Basket cell axons innervate Purkinje cell somata and proximal dendrites, stellate cells project to more distal portions of Purkinje cell dendrites and Golgi cells send axons to form synapses with granule cell dendrites. All of these synaptic relationships were present in cerebellar cultures. Absent from these cultures since they were isolated cerebella were extracerebellar afferents, including mossy and climbing fibers.

Fig.1

Circuit diagram of the major cerebellar cortical neurons and their projections. Not shown are the extracellular afferents, as they are absent in isolated organotypic cerebellar cultures. Inhibitory projections, shown as solid black lines, from Purkinje cells (P) are illustrated on the Purkinje cell on the left side of the diagram, while projections to Purkinje cells are shown on the Purkinje cell in the center. Purkinje cells are the only cortical neurons that project axons from the cortex. Their axon collaterals project to all other inhibitory cortical neurons, including other Purkinje cells. Granule cells (g) are the only excitatory neurons in the cerebellar cortex and their projections, the parallel fibers (shown as dashed lines), project to the dendrites of all other cortical neurons. Basket cell (B) axons project to Purkinje cell somata and proximal dendrites, while stellate cell (S) axons innervate more distal portions of Purkinje cell dendrites. Golgi cells (G) project multibranched axons to the dendrites of granule cells. From reference 31 with permission.

A key anatomical feature of the cultures with regard to the studies to be described are the Purkinje cell axosomatic synapses. These were derived from two sources, namely basket cell axons and Purkinje cell recurrent axon collaterals, present in a 1:1 ratio. The average number of axosomatic synapse profiles to Purkinje cell profiles in untreated control cultures was 2.20 (Table 1). This system provided an easily measurable and quantifiable sample of the population of inhibitory synapses, allowing for correlation of morphological with physiological data.

Table 1

Ratio of axosomatic synapse profiles to Purkinje cell somatic profiles in control and experimental cerebellar cultures

Cultures	No. of cell profiles	No. of synapse profiles	Mean ratio of synapse to cell profiles ± SEM	Source
Control	78	168	2.15 ± 0.15	42
PTX (2 × 10–4 M)	58	279	4.81  ±  0.35
Bicuculline	79	318	4.03  ±  0.22
Control	23	44	1.91 ± 0.34	43
Mg2 +/TTX	45	43	0.96  ±  0.15
Control	103	228	2.21 ± 0.13	48,49
Mg2 +/TTX	102	127	1.25  ±  0.10
Mg2 +/TTX/BDNF	102	235	2.30 ± 0.14*
Control	100	200	2.00 ± 0.14	48,49
Mg2 +/TTX	101	104	1.03  ±  0.11
Mg2 +/TTX/NT-3	103	107	1.04  ±  0.11
Control	100	215	2.15 ± 0.13	48,49
Mg2 +/TTX	100	121	1.21  ±  0.11
Mg2 +/TTX/NT-4	104	209	2.01 ± 0.12*
Control	93	241	2.59 ± 0.18	49
αBDNF/αNT-4	92	124	1.35  ±  0.11
(50 μg/ml each)
Control	80	183	2.29 ± 0.15	49
PTX (10–4 M)	80	277	3.46  ±  0.24
PTX/αBDNF/αNT-4	82	204	2.49 ± 0.17*
(α: 50 μg/ml each)
PTX/αBDNF/αNT-4	80	112	1.40  ±  0.15
(α: 100 μg/ml each)
Control	77	157	2.04 ± 0.14	56
αTrkB	80	261	3.26  ±  0.19
αTrkC	77	158	2.05 ± 0.17

SEM, standard error of the mean; PTX, picrotoxin; TTX, tetrodotoxin: BDNF, brain-derived neurotrophic factor; NT-3, neurotrophin-3; NT-4, neurotrophin-4; α, antibody directed to. Source numbers refer to the reference numbers from which the data were derived. Values for mean ratios of synapse to cell profiles that were significantly different from those of untreated control cultures are indicated in bold type. Asterisks indicate values not significantly different from controls because of an experimental manipulation. Statistical significance was determined by Student’s paired t- test for data from references 42 and 43, and by one-way ANOVA followed by the Tukey HSD multiple comparisons test for data from references 48, 49 and 56. Table modified from reference 31 with permission.

EFFECTS OF ACTIVITY ENHANCING AGENTS

For purposes of electrophysiological recording, cerebellar cultures attached to their collagen coated coverslips were removed from the Maximow assemblies and transferred to a chamber mounted on the stage of an inverted microscope. The nutrient medium was removed and replaced with BSS additionally buffered with 1.5 × 10–2 M HEPES. Immediately present extracellularly recorded spontaneous cortical spike discharges, primarily of Purkinje cell origin, were abundantly present in mature cerebellar cultures. Cortical surface electrical stimulation was followed by brief periods of inhibition of cortical activity.

Cortical discharge rates in mature cultures were markedly increased by acute application of anti-GABA agents, either picrotoxin (PTX), which is thought to uncouple the GABAA receptor site from the chloride channel, thus preventing the latter from opening, or bicuculline, which competitively blocks the GABAA receptor [42]. Upon incorporation of 2 × 10–4 M of either PTX or bicuculline in the culture nutrient medium at the time of explantation and recording cortical electrical activity after 3 days in vitro (DIV), low amplitude spike discharges were considerably more frequent than in control cultures. After continuous exposure to PTX or bicuculline for 13–16 DIV, however, cortical spontaneous discharge rates were reduced to about half of that for control cultures maintained in standard nutrient medium for the same period of time. Cortical electrical stimulation of cultures continuously exposed to anti-GABA agents resulted in prolonged inhibition of cortical discharges. Inhibition in response to stimulation also appeared earlier in PTX or bicuculline treated cultures, being consistently present after 8 DIV, as opposed to 12 DIV for control cultures.

Correlative structural differences between cultures exposed to anti-GABA agents and controls were evident on electron microscopic examination after 14–16 DIV. Purkinje cells in the former had twice as many inhibitory axosomatic synapses as in the latter. As shown in Table 1, the mean ratio of somatic synapse profiles to Purkinje cell soma profiles was 2.15 in the control group, 4.81 in cultures exposed to PTX and 4.03 in bicuculline treated explants. With regard to the specific identities of the synapses, both basket cell and Purkinje cell recurrent axon collateral presynaptic terminals were represented, but in a 2:1 ratio, as opposed to a 1:1 ratio in control cultures, indicating that primarily basket cells sprouted additional axon terminals to provide increased inhibition in response to enhanced neuronal activity.

EFFECTS OF ACTIVITY BLOCKING AGENTS

Cerebellar cultures maintained in the absence of neuronal activity were similarly studied [43]. Purkinje cells were silenced by blocking somatic Na+ spikes with 10–8 M of the Na+ channel blocker, tetrodotoxin (TTX), and dendritic Ca2 + spikes were blocked with 11.1 mM of the Ca2 + antagonist, Mg2 + incorporated into the nutrient medium. Upon electrophysiological recording after 13–16 DIV, control explants were immediately active after application of the recording medium. Activity-blocked cultures, however, were silent for about 10 minutes after transfer to the recording medium. Subsequently cortical discharges appeared at a slow rate, but progressively increased until they became hyperactive, including bursts of rapid spikes, by 30–40 minutes after transfer. This hyperactivity then persisted for the duration of the recording sessions, up to 2 hours.

Ultrastructural studies again correlated with the physiological findings in that activity-blocked cultures had half the number of inhibitory Purkinje cell axosomatic synapses as control cultures. The mean ratio of somatic synapse profiles to Purkinje cell soma profiles in this group of control cultures was 1.91 compared with 0.96 in cultures maintained in activity blocking agents (Table 1). The ratio of basket cell axosomatic synapses to Purkinje cell recurrent axon collateral synapses in activity-blocked cultures was 1:1, indicating that both classes of inhibitory synapses were equally affected. Electron microscopic examination of the cortical neuropil in both treated and control cultures revealed that there was no reduction of excitatory synapses in activity-blocked cultures. This result was consistent with those of earlier studies of excitatory synaptogenesis in organotypic cultures subjected to blockade of neuronal activity[44, 45].

NEUROTROPHINS AND INHIBITORY SYNAPTOGENESIS

As Rutherford et al. [30] found that effects of activity blockade on inhibitory synaptogenesis in dissociated visual cortex cultures were prevented by simultaneous exposure to exogenously applied BDNF, but not to NGF or NT-3, we pursued similar studies in our organotypic cerebellar culture system. Because TrkA, the high affinity receptor for NGF, was expressed only transiently on Purkinje cells during development [46, 47], we focused our studies on the other neurotrophins, BDNF, NT-3 and NT-4 [48, 49]. These neurotrophins were individually applied to cerebellar cultures at concentrations of 25 ng/ml medium along with activity blocking agents, TTX and elevated levels of Mg2 +, at explantation and continuously thereafter for 15 DIV. Control cultures consisted of explants maintained in standard nutrient medium and cultures exposed to activity blocking agents without neurotrophins.

Following transfer to a recording medium after 15 DIV, all cultures that had been exposed to activity-blocking agents were silent for the first 10 minutes after transfer. Subsequent to recovery from activity blockade, cultures exposed to activity blocking agents plus either BDNF or NT-4 had spontaneous cortical discharge rates similar to untreated control cultures. Cultures maintained with activity blocking agents plus NT-3 and those maintained with activity blocking agents alone developed sustained hyperactive cortical discharges 30–40 minutes after release from activity blockade.

Electron microscopic examination of the various culture groups after 15 DIV revealed that cultures exposed to activity blocking agents alone or activity blocking agents plus NT-3 had reduced numbers of Purkinje cell axosomatic synapses, while cultures treated with activity blocking agents plus either BDNF or NT-4 had Purkinje cell axosomatic synapse counts comparable to those of untreated control cultures (Table 1). The anatomical results correlated with those of the functional studies, and supported the concept that TrkB receptor ligands, BDNF and NT-4, but not the TrkC receptor ligand, NT-3, promoted inhibitory synaptogenesis in the absence of neuronal activity.

The role of endogenous neurotrophins, which appeared to be synthesized and released in an activity-dependent manner [24, 50, 51], was investigated by continuously exposing cerebellar cultures to antibodies to BDNF and NT-4 from explantation to 15 DIV [49]. Cultures treated with a combination of these antibodies at a concentration of 50 μg/ml nutrient medium each developed only half of the number of Purkinje cell axosomatic synapses as untreated control cultures (Table 1). The effect was equivalent to blockade of neuronal activity.

When neuronal activity was augmented by continuous exposure of cultures to 10–4 M PTX, which increased the number of Purkinje cell axosomatic synapses by 50% (Table 1), simultaneous exposure to the same concentration of antibodies to BDNF and NT-4 resulted in a Purkinje cell axosomatic synapse count similar to that of control cultures. Doubling the concentration of the antibodies reduced the axosomatic synapse count further to about half of the control value (Table 1).

TrkB RECEPTOR ACTIVATION

Since the studies described thus far pointed to a role for the TrkB receptor in activity-dependent inhibitory synaptogenesis, we pursued the possibility of specific antibody activation of the TrkB receptor to determine if such activation might promote inhibitory synaptogenesis. Specific antibody activation of TrkA and ephrin receptors had been described, and the effects produced were similar to the biological effects of the receptor ligands [52-55]. Cerebellar cultures were continuously exposed to antibodies (1 μg/ml nutrient medium each) to the extracellular domains of TrkB and TrkC for 15 DIV [56]. On subsequent ultrastructural examination, cultures exposed to antibody to TrkB had an approximately 60% increase in Purkinje cell axosomatic synapses above control values, while there was no increase of Purkinje cell axosomatic synapses in cultures exposed to antibody to TrkC. As shown in Table 1, the mean ratio of synapse to cell profiles in cultures treated with anti-TrkB antibody was 3.26, which compared to 2.04 for control cultures and 2.05 for explants exposed to anti-TrkC antibody. The increase in inhibitory synaptogenesis by specific antibody activation of the TrkB receptor was similar to that induced by continuous exposure of cerebellar cultures to a high dose (100 ng/ml medium) of BDNF [31]. These results included the TrkB receptor as being among those producing ligand agonistic effects by specific antibody activation and supported the concept that signaling for activity-dependent inhibitory synaptogenesis is via the TrkB receptor.

DISCUSSION AND CONCLUSIONS

In these studies we have shown that increased neuronal activity induced by exposure to anti-GABA agents in a cerebellar culture model system during development results in increased inhibitory synaptogenesis, as defined by quantitative morphological criteria, and a proportional decrease in spontaneous cortical electrical discharges. These results were in agreement with those of previous studies (20, 21, 23) and the morphological data confirmed the increase in inhibitory synapses. Blockade of neuronal activity in cerebellar cultures during development by application of TTX and elevated levels of Mg2 + had the opposite effect, as inhibitory synaptogenesis was reduced, again by quantitative morphological criteria, and cultures recovering after release from blockade of neuronal activity discharged hyperactively throughout the subsequent recording period. These findings were consistent with those of earlier work (1–20, 22) and the quantitative morphological data supported the notion of a selective failure of development of the full complement of inhibitory synapses in the absence of neuronal activity.

Following upon a study (30) in which the effects of activity blockade (a reduced percentage of GABA-immunopositive neurons and increased pyramidal cell discharge rates) in dissociated visual cortex cultures were prevented by simultaneous exposure to BDNF, but not to NGF or NT-3, we applied neurotrophins BDNF, NT-3 and NT-4 exogenously to cerebellar cultures during development under activity blockade (48, 49). The TrkB receptor ligands, BDNF and NT-4, promoted full development of inhibitory synapses during activity blockade, as determined by quantitative morphological criteria and normal spontaneous cortical discharge rates after release from blockade, but cultures exposed to the TrkC receptor ligand, NT-3, did not escape the consequences of an absence neuronal activity. As these results pointed to TrkB receptor ligands as promoters of activity-dependent inhibitory synaptogenesis, we explored properties of endogenous BDNF and NT-4 by exposing cerebellar cultures to antibodies to these ligands during development (49). The effects were similar to those of activity blockade, with a reduced development of Purkinje cell axosomatic synapses to approximately half the control level. Similar antibody exposure of cultures simultaneously treated with PTX prevented increased inhibitory synaptogenesis, as seen with cultures exposed only to PTX (42). This result suggested that increased inhibitory synaptogenesis as a consequence of increased neuronal activity is at least partially attributable to elevated levels of endogenously secreted TrkB receptor ligands. Finally we demonstrated that direct antibody activation of the TrkB receptor produced biological effects like those of application of TrkB receptor ligands (56), similar to that of previously reported effects of direct antibody activation of TrkA and ephrin receptors (52–55). This result indicated that signaling for activity-dependent inhibitory synaptogenesis is via the TrkB receptor.

Conclusions to be drawn from these studies are: 1) neuronal activity is necessary for the complete development of inhibitory circuitry, 2) TrkB receptor ligands have a role in activity-dependent inhibitory synaptogenesis and 3) signaling for activity-dependent inhibitory synaptogenesis is via the TrkB receptor. Excitatory synapses, on the other hand, develop fully in the absence of neuronal activity (43–45).

There are at least three ways of promoting inhibitory synaptogenesis, including 1) application of exogenous TrkB receptor ligands, 2) increasing release of endogenous TrkB receptor ligands by activity, such as exercise [57], and 3) activating TrkB receptors by binding with specific antibody. The possible clinical significance of these studies relates to the necessity for restoration of inhibitory circuitry after insults such as trauma or stroke, in which the balance between excitatory and inhibitory elements may be disrupted. Activity is known to promote functional recovery in both experimental and clinical conditions [57-59]. That the effects of activity appear to be mediated through TrkB receptor ligands may have therapeutic implications. It has been shown in animal studies that infusion of BDNF or measures that enhance BDNF after appropriate intervals following induction of experimental stroke improve functional recovery [60-62]. Future developments may advance such measures to the treatment of human neurological disorders.

CONFLICT OF INTEREST

There is no financial conflict of interest regarding studies from my laboratory presented in this paper.